Summary
This document is an interview-based report discussing the integration of artificial intelligence (AI) in pharmacovigilance (PV). It outlines how AI is transitioning from theoretical promise to practical application within the field. The report highlights the current use of AI-enabled tools in PV workflows, particularly in case intake and early processing, which aim to reduce manual efforts and improve data capture consistency. It also addresses the persistent barriers to broader AI adoption, such as compliance risks and the challenges posed by variable data formats. Furthermore, the report details the role of functional service partnerships (FSPs) in facilitating the implementation and scaling of AI technologies, emphasizing their expertise in designing tailored case processing flows and ensuring regulatory compliance. The document concludes with insights into anticipated innovations and regulatory developments that may impact PV in the coming years, stressing the need for companies to evaluate their processes against potential automation solutions.
